What is the next earnings date for SILO stock?
SILO PHARMA INC (SILO) will report earnings on 2026-03-26, after the market close.
SILO PHARMA INC (SILO) Forecast, Price Target & Analyst Ratings
NASDAQ:SILO • US82711P2011
Current stock price
0.3324 USD
+0.01 (+3.87%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SILO PHARMA INC (SILO).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.33 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
SILO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SILO.
In the previous month the buy percentage consensus was at a similar level.
SILO was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-08-28 | Laidlaw & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 26, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 70K | 72.1K 3.00% | 72.1K | 73.44K 1.86% | 73.44K | 73.44K | 73.44K | 73.44K | 175.84M 239,333.55% | 376.42M 114.07% | |
| EBITDA YoY % growth | N/A | N/A | -4.7M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.63M -32.00% | -3.856M -6.21% | -4.706M -22.05% | -9.574M -103.45% | -17.153M -79.17% | -26.938M -57.04% | -39.054M -44.98% | -48.396M -23.92% | 72.313M 249.42% | 248.46M 243.59% | |
| Operating Margin | -5,185.71% | -5,347.57% | -6,526.63% | -13,036.11% | -23,356.94% | -36,680.56% | -53,177.78% | -65,898.61% | 41.12% | 66.01% | |
| EPS YoY % growth | N/A | N/A | N/A 45.10% | -0.71 -25.00% | -0.73 -2.86% | -1.14 -55.56% | -1.23 -8.04% | -1.52 -23.14% | 1.32 186.58% | 4.42 235.66% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-25.99%
EPS Next 5 Year
-21.62%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
SILO PHARMA INC / SILO Forecast FAQ
How many analysts have analysed SILO PHARMA INC (SILO)?
The number of analysts covering SILO PHARMA INC (SILO) is 7.